Viewing StudyNCT00086112



Ignite Creation Date: 2024-05-05 @ 11:34 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00086112
Status: COMPLETED
Last Update Posted: 2012-07-23
First Post: 2004-06-24

Brief Title: Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC

Organization Data

Organization: Johnson Johnson Pharmaceutical Research Development LLC
Class: INDUSTRY
Study ID: CR004696
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Janssen LP INDUSTRY